Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Hasenkamp

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Critical Reviews in Oncology/Hematology|October 8, 2015
A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affectionsNarges Seyfizadeh, Nayer Seyfizadeh, Justin Hasenkamp, et al.
Case Reports in Hematology|September 1, 2012
Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow InvolvementStephan Zaenker, Stefan Schweyer, Justin Hasenkamp, et al.
Annals of Hematology|September 4, 2009
Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphomaAndrea Borgerding, Justin Hasenkamp, Bertram Glass, et al.
Clinical Oral Investigations|May 25, 2017
Oral health status in adult patients with newly diagnosed acute leukemiaRilana Busjan, Justin Hasenkamp, Gerhard Schmalz, et al.
Annals of Hematology|October 14, 2009
Relevance of target cell-induced apoptosis as mechanism of resistance against natural killer cellsJustin Hasenkamp, Andrea Borgerding, Gerald Wulf, et al.
Oral Health & Preventive Dentistry|June 10, 2020
Oral Health-Related Quality of Life in Adult Patients with Newly Diagnosed Acute LeukaemiaGerhard Schmalz, Rilana Busjan, Marit Dietl, et al.
Acta Haematologica|April 8, 2020
Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic LeukemiaEvgenii Shumilov, Justin Hasenkamp, Christoph Johannes Szuszies, et al.
Experimental Hematology|January 9, 2010
B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expressionAndrea Borgerding, Justin Hasenkamp, Michael Engelke, et al.
International Journal of Hematology|September 27, 2014
Loss of donor chimerism in remission after allogeneic stem cell transplantation of T-prolymphocytic leukemia patients following alemtuzumab induction therapyChristoph Johannes Szuszies, Justin Hasenkamp, Wolfram Jung, et al.
Experimental Hematology|June 9, 2004
Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectorsRoland Schroers, York Hildebrandt, Justin Hasenkamp, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Critical Reviews in Oncology/Hematology|October 8, 2015
A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affectionsNarges Seyfizadeh, Nayer Seyfizadeh, Justin Hasenkamp, et al.
Case Reports in Hematology|September 1, 2012
Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow InvolvementStephan Zaenker, Stefan Schweyer, Justin Hasenkamp, et al.
Annals of Hematology|September 4, 2009
Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphomaAndrea Borgerding, Justin Hasenkamp, Bertram Glass, et al.
Clinical Oral Investigations|May 25, 2017
Oral health status in adult patients with newly diagnosed acute leukemiaRilana Busjan, Justin Hasenkamp, Gerhard Schmalz, et al.
Annals of Hematology|October 14, 2009
Relevance of target cell-induced apoptosis as mechanism of resistance against natural killer cellsJustin Hasenkamp, Andrea Borgerding, Gerald Wulf, et al.
Oral Health & Preventive Dentistry|June 10, 2020
Oral Health-Related Quality of Life in Adult Patients with Newly Diagnosed Acute LeukaemiaGerhard Schmalz, Rilana Busjan, Marit Dietl, et al.
Acta Haematologica|April 8, 2020
Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic LeukemiaEvgenii Shumilov, Justin Hasenkamp, Christoph Johannes Szuszies, et al.
Experimental Hematology|January 9, 2010
B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expressionAndrea Borgerding, Justin Hasenkamp, Michael Engelke, et al.
International Journal of Hematology|September 27, 2014
Loss of donor chimerism in remission after allogeneic stem cell transplantation of T-prolymphocytic leukemia patients following alemtuzumab induction therapyChristoph Johannes Szuszies, Justin Hasenkamp, Wolfram Jung, et al.
Experimental Hematology|June 9, 2004
Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectorsRoland Schroers, York Hildebrandt, Justin Hasenkamp, et al.
Pageof 4